T cell-intrinsic requirement for NF-κB induction in postdifferentiation IFN-γ production and clonal expansion in a Th1 response

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 1816-1824

  Corn, Radiah A ^b   Aronica, Mark A ^a,c   Zhang, Fuping ^a   Tong, Yingkai ^a   Stanley, Sarah A ^a   Kim, Se Ryoung Agnes ^a   Stephenson, Linda ^a   Enerson, Ben ^a   McCarthy, Susan ^a   Mora, Ana ^a,d   Boothby, Mark ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DIMER; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; PROTEIN BCL 3; STAT PROTEIN; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TRANSACTIVATION; TRANSGENIC MOUSE;

EID: 0041589416     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.1816     Document Type: Article

References (70)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
2. Ho, I. C., and L. H. Glimcher. 2002. Transcription: tantalizing times for T cells. Cell 109:S109.
3. Malvey, E. N., M. K. Jenkins, and D. L. Mueller. 1998. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of Th1 cells. J. Immunol. 161:2168.
4. Thierfelder, W., J. van Deursen, K. Yamamoto, R. A. Tripp, S. Sarawar, R. Carson, M. Sangster, D. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171.
5. Lohoff, M., D. Ferrick, H.-W. Mittrucker, G. S. Duncan, S. Bischof, M. Rollinghoff, and T. W. Mak. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681.
6. Taki, S., T. Sato, K. Ogasawara, T. Fukuda, M. Sato, S. Hida, G. Suzuki, M. Mitsuyama, E.-H. Shin, S. Kojima, et al. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673.
7. Galon, J., C. Sudarshan, S. Ito, D. Finbloom, and J. J. O'Shea. 1999. IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J. Immunol. 162:7256.
8. Goenka, S., J. Youn, L. Dzurek, U. Schindler, L.-y. Yu-Lee, and M. Boothby. 1999. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an interferon-responsive promoter and for trans-activation. J. Immunol. 163:4663.
9. Ouyang, W., N. G. Jacobson, D. Bhattacharya, J. D. Gorham, D. Fenoglio, W. C. Sha, T. L. Murphy, and K. M. Murphy. 1999. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc. Natl. Acad. Sci. USA 96:3888.
10. Szabo, S. J., S. Kim, G. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.
11. Szabo, S. J., B. Sullivan, C. Stemmann, A. Satoskar, B. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295:338.
12. Mullen, A. C., F. A. High, A. Hutchins, H. W. Lee, A. Villarino, D. M. Livingston, A. Kung, N. Cereb, T. P. Yao, S. Y. Yang, and S. L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907.
13. + T cells. Nat. Immunol. 3:549.
14. Ghosh, S., M. May, and E. Kopp. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
15. Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107:13.
16. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
17. Das, J., C.-H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray, 2001. A critical role for p50 NF-κB1 in Gata3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.
18. Murphy, T. L., M. Cleveland, P. Kulesza, J. Magram, and K. M. Murphy. 1995. Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:5258.
19. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97:12705.
20. Hilliard, B., E. Samoilova, T. Liu, A. Rostami, and Y. Chen. 1999. Experimental autoimmune encephalomyelitis in NF-κB deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163:2937.
21. Israel. A. 2000. The IKK complex: an integrator of all signals that activate NF-κB? Trends Cell. Biol. 10:129.
22. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81.
23. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485.
24. Brockman, J. A., D. Scherer, T. McKinsey, S. Hall, X. Qi, W. Lee, and D. W. Ballard. 1995. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:2809.
25. Boothby, M., A. L. Mora, D. C. Scherer, J. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of NF-κB. J. Exp. Med. 185:1897.
26. Esslinger, C. W., A. Wilson, B. Sordat, F. Beermann, and C. V. Jongeneel. 1997. Abnormal T lymphocyte development induced by targeted overexpression of IκBα. J. Immunol. 158:5075.
27. Lee, S. Y., D. Kaufman, A. Mora, A. Santana, M. Boothby, and Y. Choi. 1998. Stimulus-dependent synergism of the anti-apoptotic TRAF2 and NF-κB pathways. J. Exp. Med. 188:1381.
28. Aronica, M. A., A. Mora, D. Mitchell, J. Johnson, P. W. Finn, J. R. Sheller, and M. Boothby, 1999. Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J. Immunol. 163:5116.
29. + T cells in their dependence on NF-κB/ Rel signaling. Eur. J. Immunol. 29:2968.
30. May, M. J., F. D'Acquisto, L. A. Madge, J. Glockner, J. S. Pober, and S. Ghosh. 2000. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289:1550.
31. low thymocytes in vivo. Science 250:1720.
32. Youn, J., J. Chen, S. Goenka, M. Aronica, A. Mora, V. Correa, J. R. Sheller, and M. Boothby. 1998. In vivo function of an IL-2Rβ/IL-4Rα cytokine receptor chimera potentiates allergic airway disease. J. Exp. Med. 188:1803.
33. Kearney, E., K. A. Pape, D. Y. Loh, and M. K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1:327.
34. Ouyang, W., S. Ranganath, K. Weindel, D. Bhattacharya, T. L. Murphy, W. C. Sha, and K. M. Murphy. 1998. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745.
35. Bahnson, A., J. Dunigan, B. Baysal, T. Mohney, R. Atchison, M. Nimgaonkar, E. Ball, and J. Barranger. 1995. Centrifugal enhancement of retrovirus-mediated gene transfer. J. Virol. Methods 54:131.
36. Schreck, R., B. Meier, D. Mannel, W. Droge, and P. A. Baeurele. 1992. Dithiocarbarmates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
37. Digicaylioglu, M., and S. A. Lipton. 2001. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature 412:641.
38. Perez, V. L., J. A. Lederer, A. H. Lichtman, and A. K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869.
39. Oyama, T., S. Ran, T. Ishida, S. Nadaf, L. Kerr, D. P. Carbone, and D. I. Gabrilovich. 1998. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 160:1224.
40. Rescigno, M., M. Martino, C. Sutherland, M. Gold, P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175.
41. + T cells: evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548.
42. Huang, H., J. Hu-Li, S. Ben-Sasson, and W. E. Paul. 1997. IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 159:3731.
43. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
44. Zhang, D. H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597.
45. Finotto, S., G. De Sanctis, H. Lehr, U. Herz, M. Buerke, M. Schipp, B. Bartsch, R. Atreya, E. Schmitt, P. Galle, et al. 2001. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193:1247.
46. + T cells during T helper (Th)1/Th2 differentiation: critical downregulatory role of IL-4. J. Exp. Med. 194:143.
47. Brasier, A. R., M. Lu, T. Hai, Y. Lu, and I. Boldogh. 2001. NF-κB-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence. J. Biol. Chem. 276:32080.
48. Franzoso, G., V. Bours, V. Azarenko, S. Park, M. Tomita-Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12:3893.
49. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50 homodimers. Cell 72:729.
50. Franzoso, G., L. Carlson, T. Scharton-Kersten, E. Shores, S. Epstein, A. Grinberg, T. Tran, E. Shacter, A. Leonardi, M. Anver, et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6:479.
51. Schwarz, E., P. Krimpenfort, A. Berns, and I. M. Verma. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11:187.
52. Rebollo, A., L. Dumoutier, J. Renauld, A. Zaballos, V. Ayllon, and A.-C. Martinez. 2000. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol. Cell. Biol. 20:3407.
53. Lederer, J. A., J. S. Liou, S. Kim, N. Rice, and A. H. Lichtman. 1996. Regulation of NF-κB activation in T helper 1 and T helper 2 cells. J. Immunol. 156:56.
54. Seetharaman, R., A. Mora, G. Nabozny, M, Boothby, and J. Chen. 1999. Essential role of T cell NF-κB activation in collagen-induced arthritis. J. Immunol. 163:1577.
55. + T cells express perturbed AP-1 and NF-κB transcription forces. Proc. Natl. Acad. Sci. USA 93:979.
56. Healy, J. I., R. Dolmetsch, L. Timmerman, J. Cyster, M. L. Thomas, G. R. Crabtree, R. S. Lewis, and C. C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6:419.
57. + T cells exposed to peripheral self-antigens. J. Immunol. 166:4399.
58. Kobayashi, K., N. Inohara, L. Hernandez, J. Galan, G. Nunez, C. A. Janeway, R. Medzhitov, and R. A. Flavell. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194.
59. Chin, A. I., P. W. Dempsey, K. Bruhn, J. F. Miller, Y. Xu, and G. Cheng. 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416:190.
60. Mitchell, T. C., D. Hildeman, R. M. Kedl, T. Teague, B. C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2:397.
61. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/AI is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136.
62. + lymphocytes. J. Immunol. 165:1743.
63. Zhang, X., T. Brunner, L. Carter, R. W. Dutton, P. Rogers, L. Bradley, T. Sato, J. C. Reed, D. Green, and S. L. Swain. 1997. Unequal death in T helper cell (Th) 1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185:1837.
64. Lu, B., H. Yu, C. Chow, B. Li, W. Zheng, R. J. Davis, and R. A. Flavell. 2001. GADD45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector Th1 cells. Immunity 14:583.
65. De Smaele, E., F. Zazzeroni, S. Papa, D. Nguyen, R. Jin, J. Jones, R. Cong, and G. Franzoso. 2001. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signaling. Nature 414:308.
66. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, and H. A. Young. 1997. Interaction of NF-κB and NFAT with the interferon-γ promoter. J. Biol. Chem. 272:30412.
67. Mora, A. L., J. Youn, A. D. Keegan, and M. Boothby. 2001. Mechanisms of NF-κB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J. Immunol. 166:2218.
68. Van Parijs, L., A. Biuckians, A. Ibragimov, F. Alt, D. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
69. Speirs, K., J. Caamano, M. H. Goldschmidt, C. A. Hunter, and P. Scott. 2002. NF-κB2 is required for optimal CD40-induced IL-12 production but dispensable for Th1 cell differentiation. J. Immunol. 168:4406.
70. Caamano, J., C. Tato, G. Cai, E. Villegas, K. Speirs, L. Craig, J. Alexander, and C. A. Hunter. 2000. Identification of a role for NF-κB2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J. Immunol. 165:5720.